logo
logo
Sign in

Cardiac Pacing Leads Are Estimated To Witness High Growth Owing To Rapid Increase In Geriatric Population

avatar
Leena Shedmake
Cardiac Pacing Leads Are Estimated To Witness High Growth Owing To Rapid Increase In Geriatric Population

Cardiac pacing leads are very thin, flexible wires that are used to deliver electrical pulses from a pacemaker to the heart. They help deliver impulses from the pacemaker to regulate abnormal heart rhythms and contractions. Cardiac pacing leads play a crucial role in cardiac pacing therapy and help improve the quality of life of patients suffering from various cardiac conditions such as bradycardia, heart blocks, and arrhythmias. The growing prevalence of cardiovascular disorders and rising geriatric population are key factors augmenting the demand for cardiac pacing leads.

The global Cardiac Pacing Leads Market is estimated to be valued at US$ 371.52 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.


Market Opportunity:


The rapidly increasing geriatric population is presenting lucrative growth opportunities for players operating in the cardiac pacing leads market. As per the WHO, the global geriatric population, aged 65 years or older, is expected to reach nearly 1.5 billion by 2050 from 703 million in 2019. Moreover, according to the United Nations Department of Economic and Social Affairs, the share of global population aged above 65 is projected to double from 7% in 2019 to 16% in 2050. The risk of cardiovascular disorders substantially increases with age. Therefore, the rising geriatric demographic will propel the demand for cardiac pacing and pacing leads for treatment of various cardiac arrhythmias and conduction disorders over the coming years. Manufacturers can gain a competitive edge by developing specialized pacing leads catering to the needs of elderly patients.


Porter’s Analysis

Threat of new entrants: The cardiac pacing leads market requires significant investment in R&D and manufacturing facilities. Established players have significant brand recognition and control over distribution channels which pose entry barriers for new players.


Bargaining power of buyers: Individual consumers have low bargaining power as they rely on physician recommendations for product choices. However, group purchasing organizations of hospitals have some negotiating power to influence prices.


Bargaining power of suppliers: Key raw material suppliers for cardiac pacing leads include makers of titanium, platinum, polyurethane and medical grade polymers. Suppliers have moderate bargaining power due to limited number of raw material alternatives and suppliers.


Threat of new substitutes: No close substitutes exist for cardiac pacing leads although alternative technologies like cardiac resynchronization therapy are emerging.


Competitive rivalry: The global cardiac pacing leads market is highly consolidated with top players holding majority share. Players compete on product innovation, brand, quality and customer service to gain market share.


SWOT Analysis


Strength: Established brands and distribution networks. Innovation in leadless pacing and remote monitoring technologies.

Weakness: High R&D and manufacturing costs. Reimbursement and regulatory hurdles.

Opportunity: Growing geriatric population and prevalence of CVDs. Emerging markets in Asia Pacific and Latin America.

Threats: Price pressures from hospitals and buying groups. Stringent product approval timelines.


Key Takeaways


The Global Cardiac Pacing Leads Market Growth  is expected to witness high over the forecast period 2024 to 2031. The market size for 2024 is US$ 371.52 Bn and projected to reach over US$ 800 Bn by 2031, rising at a CAGR of 11%.


Regional analysis: North America dominates the global cardiac pacing leads market currently owing to high disease prevalence, healthcare spending and availability of advanced treatments. However, Asia Pacific is expected to rise as the fastest growing regional market in the coming years. Rising cardiac disorders, growing medical tourism and increasing health expenditures are driving the APAC cardiac pacing leads market.


Key players: Key players operating in the cardiac pacing leads market are GE Healthcare, Boston Scientific Corporation, Medtronic, Biotronik, LivaNova, Abbott and MicroPort. GE Healthcare leads the global market share currently, while Medtronic and Boston Scientific are other major players. Players are focused on extending their product portfolio with advanced pacing technologies like leadless pacemakers to gain market share.

Explore more information on this topic, Please visit-

https://www.newsstatix.com/cardiac-pacing-leads-market-share-size-and-growth-share-trends-analysis-demand-forecast/ 

Explore more trending article Related this topic:

https://masstamilan.tv/understanding-the-human-microbiome/ 

collect
0
avatar
Leena Shedmake
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more